Board MeetingMay 20, 2026, 04:03 PM
Corvus Pharmaceuticals to Present at Jefferies & Goldman Sachs Conferences
AI Summary
Corvus Pharmaceuticals announced that its leadership team will conduct one-on-one meetings with investors and present a corporate overview at two upcoming healthcare conferences. The Jefferies Global Healthcare Conference presentation is scheduled for June 3, 2026, and the Goldman Sachs 47th Annual Global Healthcare Conference presentation is set for June 8, 2026. Webcasts of both presentations will be available live and for 90 days on the company's investor relations website. Corvus is a clinical-stage biopharmaceutical company developing ITK inhibition, with its lead candidate soquelitinib in Phase 3 and Phase 2 trials.
Key Highlights
- Corvus Pharmaceuticals leadership to present at 2026 Jefferies Global Healthcare Conference.
- Jefferies presentation scheduled for Wednesday, June 3, 2026, at 3:45 PM ET.
- Corvus leadership to present at Goldman Sachs 47th Annual Global Healthcare Conference.
- Goldman Sachs presentation scheduled for Monday, June 8, 2026, at 11:20 AM ET.
- Webcasts of both presentations will be available live and for 90 days.
- Company's lead product candidate, soquelitinib, is in Phase 3 and Phase 2 clinical trials.
Price Impact
More from CRVS